Loading viewer...
earnings
Format: PDF earnings
Karyopharm Therapeutics presented first quarter 2022 financial results and business updates on May 5, 2022, featuring commercial highlights for XPOVIO and pipeline updates for selinexor and eltanexor. The presentation covers financial guidance for 2022 net product revenue and R&D/SG&A expenses, along with clinical development progress across multiple myeloma and diffuse large B-cell lymphoma indications.
conference
34 Pages
earnings
22 Pages
A10 Networks
Saudi Reinsurance Company 2023 Year-End Earnings Presentation
earningsearnings
26 Pages
Saudi Reinsurance Company
American Vanguard Q3 2021 Earnings Call
earningsearnings
33 Pages
American Vanguard
Commonwealth Bank Australia H1 2024 Results Presentation
earningsearnings
149 Pages
Commonwealth Bank of Australia